nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Methotrexate—psoriasis	0.0939	0.169	CbGbCtD
Doxycycline—SLC22A6—Cyclosporine—psoriasis	0.0719	0.13	CbGbCtD
Doxycycline—MMP13—synovial fluid—psoriasis	0.0715	0.211	CbGeAlD
Doxycycline—CYP3A4—Calcitriol—psoriasis	0.0567	0.102	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—psoriasis	0.0546	0.0985	CbGbCtD
Doxycycline—MMP1—synovial fluid—psoriasis	0.0503	0.148	CbGeAlD
Doxycycline—MMP13—skeletal joint—psoriasis	0.0463	0.136	CbGeAlD
Doxycycline—CYP3A4—Methoxsalen—psoriasis	0.0441	0.0795	CbGbCtD
Doxycycline—SLC22A6—Methotrexate—psoriasis	0.038	0.0686	CbGbCtD
Doxycycline—MMP1—dermis—psoriasis	0.0377	0.111	CbGeAlD
Doxycycline—MMP13—synovial membrane of synovial joint—psoriasis	0.0352	0.104	CbGeAlD
Doxycycline—MMP1—skeletal joint—psoriasis	0.0326	0.0958	CbGeAlD
Doxycycline—CYP3A4—Cholecalciferol—psoriasis	0.0292	0.0527	CbGbCtD
Doxycycline—CYP3A4—Mycophenolate mofetil—psoriasis	0.0253	0.0457	CbGbCtD
Doxycycline—CYP3A4—Triamcinolone—psoriasis	0.0253	0.0457	CbGbCtD
Doxycycline—MMP1—synovial membrane of synovial joint—psoriasis	0.0247	0.0728	CbGeAlD
Doxycycline—CYP3A4—Betamethasone—psoriasis	0.0217	0.0392	CbGbCtD
Doxycycline—CYP3A4—Prednisolone—psoriasis	0.0214	0.0386	CbGbCtD
Doxycycline—CYP3A4—Hydrocortisone—psoriasis	0.0203	0.0366	CbGbCtD
Doxycycline—CYP3A4—Prednisone—psoriasis	0.0202	0.0365	CbGbCtD
Doxycycline—CYP3A4—Cyclosporine—psoriasis	0.0192	0.0346	CbGbCtD
Doxycycline—MMP1—skin epidermis—psoriasis	0.0159	0.0467	CbGeAlD
Doxycycline—CYP3A4—Dexamethasone—psoriasis	0.0126	0.0228	CbGbCtD
Doxycycline—MMP1—endothelium—psoriasis	0.0115	0.0339	CbGeAlD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IVL—psoriasis	0.00967	0.0936	CbGpPWpGaD
Doxycycline—MMP13—tendon—psoriasis	0.00532	0.0157	CbGeAlD
Doxycycline—MMP1—skin of body—psoriasis	0.00492	0.0145	CbGeAlD
Doxycycline—MMP13—Endochondral Ossification—RUNX3—psoriasis	0.00395	0.0382	CbGpPWpGaD
Doxycycline—MMP1—tendon—psoriasis	0.00374	0.011	CbGeAlD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.0035	0.0339	CbGpPWpGaD
Doxycycline—Minocycline—VEGFA—psoriasis	0.0024	1	CrCbGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.00232	0.0224	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.00223	0.0216	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.00203	0.0196	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.00202	0.0196	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.00198	0.0192	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL13—psoriasis	0.00197	0.0191	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—psoriasis	0.00186	0.018	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINB8—psoriasis	0.00185	0.0179	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ITGAL—psoriasis	0.00161	0.0156	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—NFKBIA—psoriasis	0.00148	0.0143	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CXCL8—psoriasis	0.00147	0.0142	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS2—psoriasis	0.00146	0.0141	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NFKBIA—psoriasis	0.00146	0.0141	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS2—psoriasis	0.00141	0.0136	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NFKBIA—psoriasis	0.00141	0.0136	CbGpPWpGaD
Doxycycline—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00141	0.0136	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL10—psoriasis	0.0014	0.0136	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL4—psoriasis	0.00136	0.0132	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—psoriasis	0.00136	0.0132	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—psoriasis	0.00131	0.0127	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—psoriasis	0.00128	0.0123	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—HLA-A—psoriasis	0.00123	0.0119	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TYK2—psoriasis	0.00121	0.0117	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL4—psoriasis	0.0012	0.0116	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—psoriasis	0.00119	0.0116	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—psoriasis	0.00119	0.0115	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ITGAL—psoriasis	0.00117	0.0113	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00114	0.011	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—NFKBIA—psoriasis	0.00114	0.011	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ITGAL—psoriasis	0.00113	0.011	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—psoriasis	0.00105	0.0102	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—JUN—psoriasis	0.000967	0.00936	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	0.000954	0.00923	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—NFKB1—psoriasis	0.000942	0.00912	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—JUN—psoriasis	0.000933	0.00904	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TYK2—psoriasis	0.000933	0.00903	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NFKB1—psoriasis	0.00093	0.00901	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ITGAL—psoriasis	0.000905	0.00876	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—psoriasis	0.000902	0.00873	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NFKB1—psoriasis	0.000899	0.0087	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00087	0.00842	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—psoriasis	0.000865	0.00838	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.000855	0.00827	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—STAT3—psoriasis	0.000846	0.00819	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—STAT3—psoriasis	0.000836	0.00809	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IFNG—psoriasis	0.000824	0.00797	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—STAT3—psoriasis	0.000807	0.00782	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—JUN—psoriasis	0.000775	0.0075	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CXCL8—psoriasis	0.000766	0.00741	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—NFKB1—psoriasis	0.000727	0.00704	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000726	0.00703	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	0.000726	0.00702	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.000716	0.00693	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—JUN—psoriasis	0.000712	0.00689	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—psoriasis	0.000681	0.0066	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	0.000675	0.00653	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ICAM1—psoriasis	0.000664	0.00643	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.00066	0.00639	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—JUN—psoriasis	0.000659	0.00638	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—STAT3—psoriasis	0.000653	0.00633	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000646	0.00625	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—JUN—psoriasis	0.000627	0.00607	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	0.000604	0.00584	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—psoriasis	0.000595	0.00576	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000584	0.00566	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000577	0.00558	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ITGAL—psoriasis	0.000538	0.00521	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—CP—psoriasis	0.000518	0.00502	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000499	0.00483	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ICAM1—psoriasis	0.000485	0.00469	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—REN—psoriasis	0.00048	0.00465	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000474	0.00458	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—psoriasis	0.00047	0.00455	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ICAM1—psoriasis	0.000468	0.00453	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000467	0.00452	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—psoriasis	0.000435	0.00421	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL6—psoriasis	0.00043	0.00416	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—JUN—psoriasis	0.000429	0.00415	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—psoriasis	0.000414	0.00401	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—CP—psoriasis	0.000395	0.00383	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—JUN—psoriasis	0.000385	0.00373	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL6—psoriasis	0.000379	0.00367	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ICAM1—psoriasis	0.000374	0.00362	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	0.00037	0.00359	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	0.000336	0.00325	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—CP—psoriasis	0.00033	0.00319	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE—psoriasis	0.0003	0.0029	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—psoriasis	0.000283	0.00274	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000268	0.0026	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CP—psoriasis	0.000263	0.00255	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—psoriasis	0.000254	0.00246	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000252	0.00244	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CARM1—psoriasis	0.000251	0.00243	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000248	0.0024	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS2—psoriasis	0.000221	0.00214	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000217	0.0021	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CP—psoriasis	0.000201	0.00194	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CARM1—psoriasis	0.000192	0.00185	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000187	0.00181	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—LEP—psoriasis	0.000186	0.0018	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CP—psoriasis	0.000168	0.00162	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CARM1—psoriasis	0.00016	0.00155	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—psoriasis	0.000128	0.00124	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—psoriasis	0.000124	0.0012	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—psoriasis	9.66e-05	0.000935	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NDUFA5—psoriasis	5.06e-05	0.00049	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP2S1—psoriasis	4.3e-05	0.000416	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CARM1—psoriasis	2.1e-05	0.000203	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CAT—psoriasis	1.29e-05	0.000125	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOE—psoriasis	1e-05	9.72e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARG—psoriasis	8.75e-06	8.47e-05	CbGpPWpGaD
